Form 8.3 - [Abbvie. Inc.]
March 20 2020 - 11:11AM
Dow Jones News
TIDM0QCV TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 19(th) March 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 67,959,725 4.60222%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 67,959,725 4.60222%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 1,800 71.06
-------------- ----------------------------- -----------------------
Purchase 500 71.06
-------------- ----------------------------- -----------------------
Purchase 1,000 71.06
-------------- ----------------------------- -----------------------
Purchase 2,500 71.06
-------------- ----------------------------- -----------------------
Purchase 1,600 71.06
-------------- ----------------------------- -----------------------
Purchase 142 70.29
-------------- ----------------------------- -----------------------
Purchase 1,100 71.06
-------------- ----------------------------- -----------------------
Purchase 1,800 71.06
-------------- ----------------------------- -----------------------
Purchase 596 71.06
-------------- ----------------------------- -----------------------
Purchase 1,995 71.06
-------------- ----------------------------- -----------------------
Purchase 291 71.06
-------------- ----------------------------- -----------------------
Purchase 1,552 71.06
-------------- ----------------------------- -----------------------
Purchase 69,708 71.06
-------------- ----------------------------- -----------------------
Purchase 26,376 71.06
-------------- ----------------------------- -----------------------
Purchase 105 71.06
-------------- ----------------------------- -----------------------
Purchase 2,526 71.06
-------------- ----------------------------- -----------------------
Purchase 352 71.06
-------------- ----------------------------- -----------------------
Purchase 1,408 71.06
-------------- ----------------------------- -----------------------
Purchase 538 71.06
-------------- ----------------------------- -----------------------
Purchase 569 71.06
-------------- ----------------------------- -----------------------
Sale 300 69.50
-------------- ----------------------------- -----------------------
Sale 18,500 67.94
-------------- ----------------------------- -----------------------
Sale 363 70.54
-------------- ----------------------------- -----------------------
Sale 2,100 71.06
-------------- ----------------------------- -----------------------
Sale 1,100 71.06
-------------- ----------------------------- -----------------------
Sale 1,000 71.06
-------------- ----------------------------- -----------------------
Sale 2,500 71.06
-------------- ----------------------------- -----------------------
Sale 5,000 71.06
-------------- ----------------------------- -----------------------
Sale 52,400 71.06
-------------- ----------------------------- -----------------------
Sale 500 71.06
-------------- ----------------------------- -----------------------
Sale 6,486 71.06
-------------- ----------------------------- -----------------------
Sale 126,238 71.06
-------------- ----------------------------- -----------------------
Sale 175,560 71.06
-------------- ----------------------------- -----------------------
Sale 928 71.06
-------------- ----------------------------- -----------------------
Sale 505 71.06
-------------- ----------------------------- -----------------------
Sale 35,400 71.06
-------------- ----------------------------- -----------------------
Sale 15,156 71.06
-------------- ----------------------------- -----------------------
Sale 500 71.90
-------------- ----------------------------- -----------------------
Sale 1,954 71.06
-------------- ----------------------------- -----------------------
Sale 977 71.06
-------------- ----------------------------- -----------------------
Sale 1,076 71.06
-------------- ----------------------------- -----------------------
Sale 10,100 71.06
-------------- ----------------------------- -----------------------
Sale 1,800 71.06
-------------- ----------------------------- -----------------------
Sale 1,600 71.06
-------------- ----------------------------- -----------------------
Sale 1,800 71.06
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 20(th) March 2020
------------------------------------------------------- -----------------
Contact name Lionel Colaco
------------------------------------------------------- -----------------
Telephone number 020 33956098
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
March 20, 2020 10:56 ET (14:56 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Sep 2023 to Sep 2024